Transgene Market Cap

Transgene has a market cap or net worth of €92.66 million as of December 20, 2024. Its market cap has decreased by -36.28% in one year.

Market Cap

92.66M

Enterprise Value

114.12M

Revenue

6.49M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.70

Market Cap Chart

Since March 30, 1998, Transgene's market cap has decreased from 151.86M to 92.66M, a decrease of -38.99%. That is a compound annual growth rate of -1.83%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	92.66M	-32.75%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	137.90M	6.95%
Dec 31, 2019	128.94M	-24.16%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sanofi	114.43B
EssilorLuxottica Société anonyme	105.61B
Sartorius Stedim Biotech S.A.	18.02B
bioMérieux S.A.	12.06B
Eurofins Scientific SE	9.08B
Ipsen S.A.	8.88B
Virbac SA	2.59B
Ramsay Générale de Santé SA	1.25B

Market Cap Rankings